M Sakayori

Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning--with special reference to the stem cell of the tumor.

Shunsuke Nozawa, Katsumi Tsukazaki, M Sakayori et al. · PubMed · 1988 · 50 citations

Medicine, Cell Biology, Oncology +16

Human monoclonal antibody (HMST-1) against lacto-series type 1 chain and expression of the chain in uterine endometrial cancers.

Shunsuke Nozawa, Sonoko Narisawa, Kota Kojima et al. · PubMed · 1989 · 28 citations

Medicine, Molecular Biology, Oncology +17

Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy

Shinya Sutani, Toshio Ohashi, M Sakayori et al. · Radiotherapy and Oncology · 2015 · 25 citations

Medicine, Oncology, Radiation Oncology +17

[Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma].

M Sakayori, Shunsuke Nozawa, Yasuhiro Udagawa et al. · PubMed · 1990 · 25 citations

Medicine, Cell Biology, Oncology +14

Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma.

Shiro Nozawa, M Yajima, T. Sakuma et al. · PubMed · 1990 · 23 citations

Medicine, Gynecology, Oncology +17